BUZZ- Lanrui Technology shares decline as component shortages limit growth outlook for this fiscal year
路透社2026/10/22 09:42October 22 - ** Chip equipment manufacturer Lam Research (LRCX.O) saw its share price fall 7.8% in pre-market trading to $240.59
** According to data compiled by London Stock Exchange Group (LSEG), the company is expected to post second-quarter revenue and adjusted profit above analyst expectations (link), but analysts are concerned about shortages of chips and other equipment used to manufacture LRCX products
** Wafer fab equipment (WFE) spending is estimated to be in the middle of $150 billion for 2026, with preliminary estimates for 2027 exceeding $200 billion, but supply chain bottlenecks will limit growth, CEO Timothy Archer said on a conference call
** Citigroup warned investors not to raise their growth expectations for WFE in 2027/2028 due to shortages of DRAM, PCB circuit boards, and magnets, and lowered its target price from $450 to $435
** Growth expectations have been quickly revised upward; the supply chain may need two quarters to catch up, so LAM’s earnings forecast revisions could stall before resuming upward, according to TD Cowen
** The sell-off in semiconductor stocks on Thursday also impacted the stock
** Nevertheless, 30 analysts have given the stock a “buy” or higher rating, while 4 have rated it “hold”, with a median target price of $352.50 — LSEG compiled data
** As of the last trading day’s close, the stock had risen 50% year-to-date
(To assist non-English speakers, Reuters has automated its reporting translation into several other languages. Due to possible inaccuracies or lack of necessary context in automated translations, Reuters does not guarantee the accuracy of automated translation text and provides it solely for reader convenience. Reuters assumes no responsibility for any damage or loss caused by use of the automated translation function.)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Employees Provident Fund Board Raises Stake in Sunway Healthcare to 8.402%
Harvia publishes update to financial calendar
Fundsight increases voting rights in Cherry to 7.01% from 5.35%